Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 3 boards, counting each seat separately. Longest: Spyre Therapeutics Inc., 2 years.
Spyre Therapeutics Inc.
Director · Chief Executive Officer
Oruka Therapeutics Inc.
Director
Damora Therapeutics Inc.
Director
Chief executive roles
Spyre Therapeutics Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −2,500 | $86.36 | $215,900 |
| Sep 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −8,400 | $87.15 | $732,060 |
| Sep 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −3,700 | $88.06 | $325,822 |
| Sep 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −400 | $89.07 | $35,628 |
| Aug 3, 2026 | Spyre Therapeutics Inc. | Open-market sale | −800 | $93.97 | $75,176 |
| Aug 3, 2026 | Spyre Therapeutics Inc. | Open-market sale | −7,157 | $95.10 | $680,631 |
| Aug 3, 2026 | Spyre Therapeutics Inc. | Open-market sale | −5,635 | $95.93 | $540,566 |
| Aug 3, 2026 | Spyre Therapeutics Inc. | Open-market sale | −1,392 | $96.82 | $134,773 |
| Aug 3, 2026 | Spyre Therapeutics Inc. | Open-market sale | −16 | $97.46 | $1,559 |
| Jul 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −10,176 | $87.44 | $889,789 |
| Jul 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −4,234 | $88.12 | $373,100 |
| Jul 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −590 | $88.91 | $52,457 |
| Jun 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −3,557 | $69.40 | $246,856 |
| Jun 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −8,149 | $70.50 | $574,505 |
| Jun 1, 2026 | Spyre Therapeutics Inc. | Open-market sale | −3,294 | $71.38 | $235,126 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.